Some diabetics may also be at risk for low thiamin levels [1]
The outcome of glycolysis is increased levels of ATP within the -cell
Medication Access May Shift Toward Non-Brand Options Patients could be transitioned to: Generic medications (when available) Off-label metabolic therapies Medically supervised weight-management programs 5
Author contribution statement AMB, PHE, DEQ, JSD, CHC, and JRH contributed to the experimental design of these studies
Abdomen sites (avoiding the 2" navel radius) absorb most consistently
In November 2025, the Trump administration announced TrumpRx, a federal direct purchasing platform using tariff threats to extract Most Favored Nation (MFN) pricing from pharmaceutical manufacturers & bringing the cost of GLP-1s like Ozempic down to $350/month for cash payers (from $1,350/month)